Cargando…

Assessing potential surge of COVID-19 cases and the need for booster vaccine amid emerging SARS-CoV-2 variants in Indonesia: A modelling study from West Java

OBJECTIVES: Primary and booster vaccinations are crucial in COVID-19 control. This study aimed to assess the minimum booster coverage to hamper potential surge of COVID-19 cases in 2023 in Indonesia, a low-resource setting country. METHODS: We used a modified SEIR compartment model to assess differe...

Descripción completa

Detalles Bibliográficos
Autores principales: Nuraini, Nuning, Soekotjo, Fadiya Nadhilah, Alifia, Almira, Sukandar, Kamal Khairudin, Lestari, Bony Wiem
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10559733/
https://www.ncbi.nlm.nih.gov/pubmed/37809646
http://dx.doi.org/10.1016/j.heliyon.2023.e20009
_version_ 1785117568929890304
author Nuraini, Nuning
Soekotjo, Fadiya Nadhilah
Alifia, Almira
Sukandar, Kamal Khairudin
Lestari, Bony Wiem
author_facet Nuraini, Nuning
Soekotjo, Fadiya Nadhilah
Alifia, Almira
Sukandar, Kamal Khairudin
Lestari, Bony Wiem
author_sort Nuraini, Nuning
collection PubMed
description OBJECTIVES: Primary and booster vaccinations are crucial in COVID-19 control. This study aimed to assess the minimum booster coverage to hamper potential surge of COVID-19 cases in 2023 in Indonesia, a low-resource setting country. METHODS: We used a modified SEIR compartment model to assess different scenarios in booster coverage across West Java population: 35%, 50%, and 70%. We fitted the model, then we calculated the potential active cases in 2023 if each scenario was met before 2022 ends. A heat map of predicted cases from various booster coverages and time frames was produced and matched with vaccination rate's function to determine feasible time frames. RESULTS: A minimum of 70% booster coverage in West Java is needed to reduce 90% of potential COVID-19 cases and avert possible surge in 2023. The booster doses should be distributed before February 2023 to achieve its optimum preventive effect. Delays in achieving minimum booster coverage is acceptable, but higher booster coverage will be required. CONCLUSIONS: For better COVID-19 control in Indonesia, booster vaccination is warranted, as presented by a case study in West Java. Sufficient vaccine supplies, infrastructure, and healthcare workers should be ensured to support a successful booster vaccination program.
format Online
Article
Text
id pubmed-10559733
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-105597332023-10-08 Assessing potential surge of COVID-19 cases and the need for booster vaccine amid emerging SARS-CoV-2 variants in Indonesia: A modelling study from West Java Nuraini, Nuning Soekotjo, Fadiya Nadhilah Alifia, Almira Sukandar, Kamal Khairudin Lestari, Bony Wiem Heliyon Research Article OBJECTIVES: Primary and booster vaccinations are crucial in COVID-19 control. This study aimed to assess the minimum booster coverage to hamper potential surge of COVID-19 cases in 2023 in Indonesia, a low-resource setting country. METHODS: We used a modified SEIR compartment model to assess different scenarios in booster coverage across West Java population: 35%, 50%, and 70%. We fitted the model, then we calculated the potential active cases in 2023 if each scenario was met before 2022 ends. A heat map of predicted cases from various booster coverages and time frames was produced and matched with vaccination rate's function to determine feasible time frames. RESULTS: A minimum of 70% booster coverage in West Java is needed to reduce 90% of potential COVID-19 cases and avert possible surge in 2023. The booster doses should be distributed before February 2023 to achieve its optimum preventive effect. Delays in achieving minimum booster coverage is acceptable, but higher booster coverage will be required. CONCLUSIONS: For better COVID-19 control in Indonesia, booster vaccination is warranted, as presented by a case study in West Java. Sufficient vaccine supplies, infrastructure, and healthcare workers should be ensured to support a successful booster vaccination program. Elsevier 2023-09-09 /pmc/articles/PMC10559733/ /pubmed/37809646 http://dx.doi.org/10.1016/j.heliyon.2023.e20009 Text en © 2023 The Authors https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Research Article
Nuraini, Nuning
Soekotjo, Fadiya Nadhilah
Alifia, Almira
Sukandar, Kamal Khairudin
Lestari, Bony Wiem
Assessing potential surge of COVID-19 cases and the need for booster vaccine amid emerging SARS-CoV-2 variants in Indonesia: A modelling study from West Java
title Assessing potential surge of COVID-19 cases and the need for booster vaccine amid emerging SARS-CoV-2 variants in Indonesia: A modelling study from West Java
title_full Assessing potential surge of COVID-19 cases and the need for booster vaccine amid emerging SARS-CoV-2 variants in Indonesia: A modelling study from West Java
title_fullStr Assessing potential surge of COVID-19 cases and the need for booster vaccine amid emerging SARS-CoV-2 variants in Indonesia: A modelling study from West Java
title_full_unstemmed Assessing potential surge of COVID-19 cases and the need for booster vaccine amid emerging SARS-CoV-2 variants in Indonesia: A modelling study from West Java
title_short Assessing potential surge of COVID-19 cases and the need for booster vaccine amid emerging SARS-CoV-2 variants in Indonesia: A modelling study from West Java
title_sort assessing potential surge of covid-19 cases and the need for booster vaccine amid emerging sars-cov-2 variants in indonesia: a modelling study from west java
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10559733/
https://www.ncbi.nlm.nih.gov/pubmed/37809646
http://dx.doi.org/10.1016/j.heliyon.2023.e20009
work_keys_str_mv AT nuraininuning assessingpotentialsurgeofcovid19casesandtheneedforboostervaccineamidemergingsarscov2variantsinindonesiaamodellingstudyfromwestjava
AT soekotjofadiyanadhilah assessingpotentialsurgeofcovid19casesandtheneedforboostervaccineamidemergingsarscov2variantsinindonesiaamodellingstudyfromwestjava
AT alifiaalmira assessingpotentialsurgeofcovid19casesandtheneedforboostervaccineamidemergingsarscov2variantsinindonesiaamodellingstudyfromwestjava
AT sukandarkamalkhairudin assessingpotentialsurgeofcovid19casesandtheneedforboostervaccineamidemergingsarscov2variantsinindonesiaamodellingstudyfromwestjava
AT lestaribonywiem assessingpotentialsurgeofcovid19casesandtheneedforboostervaccineamidemergingsarscov2variantsinindonesiaamodellingstudyfromwestjava